Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in Clin Cardiol Retrieve available abstracts of 145 articles: HTML format

Single Articles

May 2024
1. TIAN X, Li X, Zhang Q, Qiao X, et al
   Improving therapeutic outcomes in heart failure with reduced nonvalvular ejection fraction: A clinical study of heart failure education intervention.
   Clin Cardiol. 2024;47:e24265.
   PubMed     Abstract available
   
   
   April 2024
2. ITO R, Kondo Y, Nakano M, Kajiyama T, et al
   Interaction of left ventricular size with the outcome of cardiac resynchronization therapy in Japanese patients.
   Clin Cardiol. 2024;47:e24267.
   PubMed     Abstract available
   
   
   March 2024
3. NABI R, Zahid T, Farooqi HA
   Utilizing machine learning for predicting heart failure outcomes: A path toward developing a patient-centered approach.
   Clin Cardiol. 2024;47:e24260.
   PubMed    
   
   
   February 2024
4. ZHENG S, Li L, Jiang C, He L, et al
   Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.
   Clin Cardiol. 2024;47:e24233.
   PubMed     Abstract available
   
   
   
5. ERGUI I, Salama J, Hooda U, Ebner B, et al
   In-hospital outcomes in unhoused patients with cardiogenic shock in the United States: Insights from The National Inpatient Sample 2011-2019.
   Clin Cardiol. 2024;47:e24235.
   PubMed     Abstract available
   
   
   
6. OSTROWSKA B, Lind L, Blomstrom-Lundqvist C
   An association between heart rate variability and incident heart failure in an elderly cohort.
   Clin Cardiol. 2024;47:e24241.
   PubMed     Abstract available
   
   
   
7. KETABI M, Andishgar A, Fereidouni Z, Sani MM, et al
   Predicting the risk of mortality and rehospitalization in heart failure patients: A retrospective cohort study by machine learning approach.
   Clin Cardiol. 2024;47:e24239.
   PubMed     Abstract available
   
   
   
8. YUE Y, Wu X, Guan X, Wu X, et al
   The prognostic value of the visually assessed time difference between mitral valve and tricuspid valve opening score for patients with heart failure with mildly reduced ejection fraction.
   Clin Cardiol. 2024;47:10.
   PubMed     Abstract available
   
   
   
9. BANFI-BACSARDI F, Pilecky D, Vamos M, Majoros Z, et al
   The effect of kidney function on guideline-directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction.
   Clin Cardiol. 2024;47:e24244.
   PubMed     Abstract available
   
   
   
10. PAN J, Liu M, Huang J, Chen L, et al
    Impact of anemia on clinical outcomes in patients with acute heart failure: A systematic review and meta-analysis.
    Clin Cardiol. 2024;47:e24228.
    PubMed     Abstract available
    
    
    
11. KIM JH, Yoon YC, Kim YH, Park JI, et al
    Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.
    Clin Cardiol. 2024;47:e24248.
    PubMed     Abstract available
    
    
    January 2024
12. NIJSKENS CM, Thomas EG, Rhodius-Meester HFM, Daemen MJAP, et al
    Is it time for Heart-Brain clinics? A clinical survey and proposition to improve current care for cognitive problems in heart failure.
    Clin Cardiol. 2024 Jan 6. doi: 10.1002/clc.24200.
    PubMed     Abstract available
    
    
    
13. SAWAN MA, Prabakaran S, D'Souza M, Behbahani-Nejad O, et al
    A systematic review of present and future pharmaco-structural therapies for hypertrophic cardiomyopathy.
    Clin Cardiol. 2024;47:e24207.
    PubMed     Abstract available
    
    
    
14. TSAI TH, Tsai ML, Chen DY, Lin Y, et al
    Evaluating the applicability of ivabradine in acute heart failure.
    Clin Cardiol. 2024;47:e24206.
    PubMed     Abstract available
    
    
    December 2023
15. HE CJ, Zhu CY, Fan HY, Qian YZ, et al
    Low T3 syndrome predicts more adverse events in patients with hypertrophic cardiomyopathy.
    Clin Cardiol. 2023;46:1569-1577.
    PubMed     Abstract available
    
    
    
16. LIN J, Wu H, Zhang T
    The correlation of left atrial diameter with preserved ejection fraction, reduced ejection fraction, and mid-range ejection fraction.
    Clin Cardiol. 2023;46:1588-1593.
    PubMed     Abstract available
    
    
    November 2023
17. GOMEZ-MESA JE, Gutierrez-Posso JM, Escalante-Forero M, Cordoba-Melo BD, et al
    American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients.
    Clin Cardiol. 2023 Nov 30. doi: 10.1002/clc.24182.
    PubMed     Abstract available
    
    
    
18. MANITO N, Cepeda-Rodrigo JM, Farre N, Castillo Orive M, et al
    Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban.
    Clin Cardiol. 2023 Nov 29. doi: 10.1002/clc.24189.
    PubMed     Abstract available
    
    
    
19. JI Q
    A meta-analysis investigating the efficacy and adverse events linked to sacubitril-valsartan in various heart failure subtypes.
    Clin Cardiol. 2023 Nov 27. doi: 10.1002/clc.24192.
    PubMed     Abstract available
    
    
    
20. SU Z, Tian S, Liang W, Wu L, et al
    Association between omentin-1 and heart failure with preserved ejection fraction in Chinese elderly patients.
    Clin Cardiol. 2023 Nov 8. doi: 10.1002/clc.24181.
    PubMed     Abstract available
    
    
    October 2023
21. TAHA AM, Hendi NI, Elwekel AB, Atia A, et al
    Cryoballoon ablation for atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Oct 25. doi: 10.1002/clc.24177.
    PubMed     Abstract available
    
    
    
22. WANG J, Huang S, Hou J, Feng K, et al
    Impact of heart failure and preoperative platelet count on the postoperative short-term outcome in infective endocarditis patients.
    Clin Cardiol. 2023 Oct 10. doi: 10.1002/clc.24171.
    PubMed     Abstract available
    
    
    
23. LIU Z, Zhu Y, Zhang L, Wu M, et al
    Red blood cell count and risk of adverse outcomes in patients with mildly reduced left ventricular ejection fraction.
    Clin Cardiol. 2023;46:1276-1284.
    PubMed     Abstract available
    
    
    
24. CHEN M, Shi J, Zhang Y, Ge X, et al
    Comparative cost analysis of implanting devices in different cardiac resynchronization therapeutic strategies.
    Clin Cardiol. 2023;46:1227-1233.
    PubMed     Abstract available
    
    
    September 2023
25. CHEN H, Liu F, Luo J, Tu Y, et al
    Association of living alone with clinical outcomes in patients with heart failure: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Sep 22. doi: 10.1002/clc.24153.
    PubMed     Abstract available
    
    
    
26. ZAKIEV V, Gvozdeva A, Skotnikov A
    Comment on: Association between the beta-blockers, calcium channel blockers, all-cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Clin Cardiol. 2023 Sep 19. doi: 10.1002/clc.24125.
    PubMed    
    
    
    
27. YIFAN T, Yanling H, Weiyun W, Xiaolin H, et al
    Mediation analysis of activities of daily living and kinesiophobia in association between cardiac function and health status of patients with chronic heart failure.
    Clin Cardiol. 2023 Sep 14. doi: 10.1002/clc.24147.
    PubMed     Abstract available
    
    
    
28. MA Y, Liu J, Sun J, Cui Y, et al
    Composite dietary antioxidant index and the risk of heart failure: A cross-sectional study from NHANES.
    Clin Cardiol. 2023 Sep 8. doi: 10.1002/clc.24144.
    PubMed     Abstract available
    
    
    
29. JIN U, Yoon M, Ha J, Lee SH, et al
    Association between frailty and physical performance in older patients with heart failure.
    Clin Cardiol. 2023 Sep 7. doi: 10.1002/clc.24142.
    PubMed     Abstract available
    
    
    August 2023
30. CELIK A, Surmeli AO, Demir M, Esen K, et al
    The diagnostic value of chest X-ray scanning by the help of Artificial Intelligence in Heart Failure (ART-IN-HF).
    Clin Cardiol. 2023 Aug 31. doi: 10.1002/clc.24105.
    PubMed     Abstract available
    
    
    
31. KIUCHI S, Hisatake S, Kabuki T, Dobashi S, et al
    Importance of anemia in heart failure over blood pressure variability.
    Clin Cardiol. 2023 Aug 30. doi: 10.1002/clc.24141.
    PubMed     Abstract available
    
    
    
32. ZHENG X, Liu M, Wu Z, Jia Z, et al
    Identifying the causal relationship between sedentary behavior and heart failure: Insights from a Mendelian randomization study and mediation analysis.
    Clin Cardiol. 2023 Aug 29. doi: 10.1002/clc.24101.
    PubMed     Abstract available
    
    
    
33. AHMAD CHEEMA H, Azeem S, Ejaz A, Khan F, et al
    Efficacy and safety of torsemide versus furosemide in heart failure patients: A systematic review of randomized controlled trials.
    Clin Cardiol. 2023 Aug 22. doi: 10.1002/clc.24088.
    PubMed    
    
    
    
34. GOMEZ DOBLAS JJ, Cepeda-Rodrigo JM, Agra Bermejo R, Blanco Labrador E, et al
    Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study.
    Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24106.
    PubMed     Abstract available
    
    
    
35. ZHOU J, Jin X, Zhou J, Xu Y, et al
    Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry.
    Clin Cardiol. 2023 Aug 14. doi: 10.1002/clc.24114.
    PubMed     Abstract available
    
    
    
36. HAMAD EA, Byku M, Larson SB, Billia F, et al
    LVAD therapy as a catalyst to heart failure remission and myocardial recovery.
    Clin Cardiol. 2023 Aug 1. doi: 10.1002/clc.24094.
    PubMed     Abstract available
    
    
    July 2023
37. WANG Y, Hou R, Ni B, Jiang Y, et al
    Development and validation of a prediction model based on machine learning algorithms for predicting the risk of heart failure in middle-aged and older US people with prediabetes or diabetes.
    Clin Cardiol. 2023 Jul 31. doi: 10.1002/clc.24104.
    PubMed     Abstract available
    
    
    
38. WANG Y, Pu X, Zhu Z, Sun W, et al
    Handgrip strength and the prognosis of patients with heart failure: A meta-analysis.
    Clin Cardiol. 2023 Jul 19. doi: 10.1002/clc.24063.
    PubMed     Abstract available
    
    
    
39. MO X, Lu P, Yang X
    Efficacy of sacubitril-valsartan and SGLT2 inhibitors in heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Jul 19. doi: 10.1002/clc.24085.
    PubMed     Abstract available
    
    
    
40. COOPER L, DeVore A, Cowger J, Pinney S, et al
    Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy.
    Clin Cardiol. 2023 Jul 18. doi: 10.1002/clc.24080.
    PubMed     Abstract available
    
    
    
41. SOUROUR N, Riveland E, Naesgaard P, Kjekshus H, et al
    N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study.
    Clin Cardiol. 2023 Jul 3. doi: 10.1002/clc.24074.
    PubMed     Abstract available
    
    
    June 2023
42. LIU X, Huang L, Tse G, Liu T, et al
    Effects of sacubitril-valsartan in the treatment of chronic heart failure patients with end-stage renal disease undergoing dialysis.
    Clin Cardiol. 2023 Jun 28. doi: 10.1002/clc.24075.
    PubMed     Abstract available
    
    
    
43. NOBAH AMA, Abuheit EMI, Jian L, Wang X, et al
    Clinical assessment of VSR site and size and its relation to the severity of heart failure in post-myocardial infarction ventricular septal rupture patients.
    Clin Cardiol. 2023 Jun 20. doi: 10.1002/clc.24062.
    PubMed     Abstract available
    
    
    
44. DIAZ-AROCUTIPA C, Denegri-Galvan J, Vicent L, Pariona M, et al
    The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta-analysis and trial sequential analysis.
    Clin Cardiol. 2023 Jun 20. doi: 10.1002/clc.24033.
    PubMed     Abstract available
    
    
    
45. MARCUS G, Kofman N, Maymon SL, Asher E, et al
    Marital status impact on the outcomes of patients admitted for acute decompensation of heart failure: A retrospective, single-center, analysis.
    Clin Cardiol. 2023 Jun 12. doi: 10.1002/clc.24053.
    PubMed     Abstract available
    
    
    
46. LLACER P, Nunez J, Croset F, Garcia M, et al
    Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction.
    Clin Cardiol. 2023 Jun 7. doi: 10.1002/clc.24040.
    PubMed     Abstract available
    
    
    
47. WU M, Ni D, Huang LL, Qiu S, et al
    Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Clin Cardiol. 2023 Jun 4. doi: 10.1002/clc.24058.
    PubMed     Abstract available
    
    
    
48. MOHTY D, Nasr S, Ragy H, Farhan HA, et al
    Cardiac amyloidosis: A survey of current awareness, diagnostic modalities, treatment practices, and clinical challenges among cardiologists in selected Middle Eastern countries.
    Clin Cardiol. 2023;46:648-655.
    PubMed     Abstract available
    
    
    May 2023
49. YAN X, Ye J, Chen H, Jiang Y, et al
    Correlation between serum laminin level and prognosis of acute heart failure.
    Clin Cardiol. 2023 May 31. doi: 10.1002/clc.24056.
    PubMed     Abstract available
    
    
    
50. ZHOU P, Huang L, Zhai M, Huang Y, et al
    Prognostic role and relationship of thyroid dysfunction and lipid profile in hospitalized heart failure patients.
    Clin Cardiol. 2023 May 25. doi: 10.1002/clc.24057.
    PubMed     Abstract available
    
    
    
51. CHEN W, Chen M, Qiao X
    Interaction of lactate/albumin and geriatric nutritional risk index on the all-cause mortality of elderly patients with critically ill heart failure: A cohort study.
    Clin Cardiol. 2023 May 24. doi: 10.1002/clc.24029.
    PubMed     Abstract available
    
    
    
52. YU GI, Kim TH, Cho YH, Bae JS, et al
    Left bundle branch area pacing in mildly reduced heart failure: A systematic literature review and meta-analysis.
    Clin Cardiol. 2023 May 5. doi: 10.1002/clc.24028.
    PubMed     Abstract available
    
    
    
53. DHANDE M, Aronis KN, Thoma F, Mulukutla S, et al
    Ventricular conduction abnormality in patients with mild to moderate cardiomyopathy.
    Clin Cardiol. 2023;46:543-548.
    PubMed     Abstract available
    
    
    April 2023
54. QIN J, Xiong J, Chen C, Wang X, et al
    Influencing factors of kinesiophobia in older patients with chronic heart failure: A structural equation model.
    Clin Cardiol. 2023 Apr 28. doi: 10.1002/clc.24024.
    PubMed     Abstract available
    
    
    
55. IMAMURA T
    Detailed association between red blood cell distribution width and heart failure.
    Clin Cardiol. 2023 Apr 24. doi: 10.1002/clc.24023.
    PubMed    
    
    
    
56. FENG Y, Ning L, Zhang J, Wang H, et al
    Prognosis and subtype analysis of left ventricular noncompaction in adults: A retrospective multicenter study.
    Clin Cardiol. 2023;46:390-396.
    PubMed     Abstract available
    
    
    March 2023
57. YIN C, Li J, Yuan L
    Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2023 Mar 2. doi: 10.1002/clc.23994.
    PubMed    
    
    
    
58. ZHANG W, Chen L, Zhou X, Huang J, et al
    Resynchronization effects and clinical outcomes during left bundle branch area pacing with and without conduction system capture.
    Clin Cardiol. 2023;46:287-295.
    PubMed     Abstract available
    
    
    
59. SHIMODA T, Imanishi R, Kou N, Okamura Y, et al
    Influence of antidiabetic medications on predictive aptitude of TyG index for HFpEF.
    Clin Cardiol. 2023;46:345.
    PubMed    
    
    
    February 2023
60. CHEN W, Lin G, Dai C, Xu K, et al
    Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
    PubMed     Abstract available
    
    
    
61. PALAU P, Mendez J, Santas E, Nunez J, et al
    Maximal functional capacity in subjects with isolated left bundle branch block: A pilot study.
    Clin Cardiol. 2023 Feb 8. doi: 10.1002/clc.23977.
    PubMed     Abstract available
    
    
    January 2023
62. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23972.
    PubMed    
    
    
    
63. MEI K, Ling Q, Gao Y, Liu X, et al
    Letter to the editor: Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: The contribution of previous heart failure to heart failure hospitalization may be overestimated.
    Clin Cardiol. 2023 Jan 19. doi: 10.1002/clc.23973.
    PubMed    
    
    
    
64. ZHANG X, Sun Y, Li Y, Wang C, et al
    Association between visceral adiposity index and heart failure: A cross-sectional study.
    Clin Cardiol. 2023 Jan 18. doi: 10.1002/clc.23976.
    PubMed     Abstract available
    
    
    
65. CHEN WW, Jiang J, Gao J, Zhang XZ, et al
    Efficacy and safety of low-dose sacubitril/valsartan in heart failure patients: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Jan 17. doi: 10.1002/clc.23971.
    PubMed     Abstract available
    
    
    
66. CHEN R, Xu J, Wang Y, Jiang B, et al
    Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta-analysis and systematic review.
    Clin Cardiol. 2023 Jan 16. doi: 10.1002/clc.23970.
    PubMed     Abstract available
    
    
    December 2022
67. YANG Y, Wu D, Wang H, Wang Y, et al
    Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Clin Cardiol. 2022;45:1184-1191.
    PubMed     Abstract available
    
    
    November 2022
68. LIAO LP, Yang Y
    Response to letter to the editor entitled: "Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients".
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23943.
    PubMed    
    
    
    
69. NAKAGAWA Y, Imamura T
    Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23953.
    PubMed    
    
    
    
70. HAO Z, Xu G, Yuan M, Sun Y, et al
    The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23952.
    PubMed     Abstract available
    
    
    
71. MEI K, Ling Q, Yan Z
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23944.
    PubMed    
    
    
    
72. LEE HW, Huang CC, Yang CY, Leu HB, et al
    Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review.
    Clin Cardiol. 2022 Nov 7. doi: 10.1002/clc.23934.
    PubMed     Abstract available
    
    
    September 2022
73. HUANG B, Huang Y, Zhai M, Zhou Q, et al
    Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients.
    Clin Cardiol. 2022 Sep 30. doi: 10.1002/clc.23925.
    PubMed     Abstract available
    
    
    
74. PICCIRILLO G, Moscucci F, Carnovale M, Bertani G, et al
    QT and Tpeak-Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data.
    Clin Cardiol. 2022 Sep 9. doi: 10.1002/clc.23888.
    PubMed     Abstract available
    
    
    
75. BLAGOVA O, Lutokhina Y, Kogan E, Kukleva A, et al
    Chronic biopsy proven post-COVID myoendocarditis with SARS-Cov-2 persistence and high level of antiheart antibodies.
    Clin Cardiol. 2022;45:952-959.
    PubMed     Abstract available
    
    
    August 2022
76. AHLGRIM C, Seiler F, Birkner P, Schoechlin S, et al
    Clinically unrecognized plasma volume expansion predicts long-term all-cause-mortality in chronic heart failure.
    Clin Cardiol. 2022 Aug 3. doi: 10.1002/clc.23893.
    PubMed     Abstract available
    
    
    
77. SHANG W, Zhang Y, Han D
    Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2022 Aug 2. doi: 10.1002/clc.23889.
    PubMed     Abstract available
    
    
    July 2022
78. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    PubMed     Abstract available
    
    
    
79. LIU YX, Chen W, Lin X, Zhu YL, et al
    Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.
    Clin Cardiol. 2022 Jul 23. doi: 10.1002/clc.23880.
    PubMed     Abstract available
    
    
    
80. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available
    
    
    
81. VICTORIA-CASTRO AM, Martin M, Yamamoto Y, Ahmad T, et al
    Pragmatic randomized trial assessing the impact of digital health technology on quality of life in patients with heart failure: Design, rationale and implementation.
    Clin Cardiol. 2022 Jul 12. doi: 10.1002/clc.23848.
    PubMed     Abstract available
    
    
    
82. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    PubMed     Abstract available
    
    
    June 2022
83. LIAO LP, Yang Y, Wu Y, Li W, et al
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Jun 29. doi: 10.1002/clc.23881.
    PubMed     Abstract available
    
    
    
84. NAKAGAWA Y, Imamura T
    Detailed association between the etiologies of heart failure and occurrence of sleep-disordered breathing.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23875.
    PubMed    
    
    
    
85. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed     Abstract available
    
    
    
86. DEVORE AD, Bosworth HB, Granger BB
    Improving implementation of evidence-based therapies for heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S52-S59.
    PubMed     Abstract available
    
    
    
87. TALHA KM, Butler J
    Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S31-S39.
    PubMed     Abstract available
    
    
    
88. MCMURRAY JJV, Docherty KF
    Insights into foundational therapies for heart failure with reduced ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S26-S30.
    PubMed     Abstract available
    
    
    
89. CHANDRAMOULI C, Stewart S, Almahmeed W, Lam CSP, et al
    Clinical implications of the universal definition for the prevention and treatment of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S2-S12.
    PubMed     Abstract available
    
    
    
90. FONAROW GC
    Advances in the management of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S1.
    PubMed    
    
    
    
91. OSTROMINSKI JW, Vaduganathan M
    Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S40-S51.
    PubMed     Abstract available
    
    
    
92. HAMMOND MM, Everitt IK, Khan SS
    New strategies and therapies for the prevention of heart failure in high-risk patients.
    Clin Cardiol. 2022;45 Suppl 1:S13-S25.
    PubMed     Abstract available
    
    
    May 2022
93. LIANG L, Huang L, Zhao X, Zhao L, et al
    Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure.
    Clin Cardiol. 2022 May 27. doi: 10.1002/clc.23850.
    PubMed     Abstract available
    
    
    
94. GU G, Wu J, Gao X, Liu M, et al
    Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.
    Clin Cardiol. 2022 May 11. doi: 10.1002/clc.23841.
    PubMed     Abstract available
    
    
    
95. WANG T, Yu FC, Wei Q, Xu X, et al
    Sleep-disordered breathing in heart failure patients with different etiologies.
    Clin Cardiol. 2022 May 10. doi: 10.1002/clc.23840.
    PubMed     Abstract available
    
    
    
96. GUERRA F, D'Onofrio A, De Ruvo E, Manzo M, et al
    Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm.
    Clin Cardiol. 2022 May 3. doi: 10.1002/clc.23832.
    PubMed     Abstract available
    
    
    April 2022
97. ROTH ME, Chinn ME, Dunn SP, Bilchick KC, et al
    Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Clin Cardiol. 2022 Apr 28. doi: 10.1002/clc.23830.
    PubMed     Abstract available
    
    
    March 2022
98. DEL CID FRATTI J, Salazar M, Argueta-Sosa EE
    Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23800.
    PubMed     Abstract available
    
    
    
99. LAUFER-PERL M, Sadon S, Zahler D, Milwidsky A, et al
    Repetitive milrinone therapy in ambulatory advanced heart failure patients.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23802.
    PubMed     Abstract available
    
    
    
100. WEN XS, Luo R, Liu J, Liu ZQ, et al
     The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
     Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
     PubMed     Abstract available
     
     
     
101. LEAHOVA-CERCHEZ X, Berthelot E, Genet B, Hanon O, et al
     Estimation of the plasma volume status of elderly patients with acute decompensated heart failure using bedside clinical, biological, and ultrasound parameters.
     Clin Cardiol. 2022 Mar 2. doi: 10.1002/clc.23791.
     PubMed     Abstract available
     
     
     February 2022
102. KRITTAYAPHONG R, Pumprueg S, Sairat P
     Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation.
     Clin Cardiol. 2022 Feb 21. doi: 10.1002/clc.23799.
     PubMed     Abstract available
     
     
     
103. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
     Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial.
     Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23796.
     PubMed     Abstract available
     
     
     
104. HWANG JW, Kim DG, Kim H, Kwak JJ, et al
     Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
     Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23792.
     PubMed     Abstract available
     
     
     
105. AMBROSY AP, Malik UI, Leong TK, Allen AR, et al
     Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic.
     Clin Cardiol. 2022 Feb 2. doi: 10.1002/clc.23761.
     PubMed     Abstract available
     
     
     January 2022
106. PARK J, Zhong X, Babaie Sarijaloo F, Wokhlu A, et al
     Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
     Clin Cardiol. 2022 Jan 25. doi: 10.1002/clc.23780.
     PubMed     Abstract available
     
     
     
107. COOPER LB, Bruce S, Psotka M, Mentz R, et al
     Proteomic differences among patients with heart failure taking furosemide or torsemide.
     Clin Cardiol. 2022 Jan 11. doi: 10.1002/clc.23733.
     PubMed     Abstract available
     
     
     
108. LIANG M, Bian B, Yang Q
     Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
     Clin Cardiol. 2022;45:5-17.
     PubMed     Abstract available
     
     
     December 2021
109. KONIG S, Pellissier V, Leiner J, Hohenstein S, et al
     Expected and observed in-hospital mortality in heart failure patients before and during the COVID-19 pandemic: Introduction of the machine learning-based standardized mortality ratio at Helios hospitals.
     Clin Cardiol. 2021 Dec 23. doi: 10.1002/clc.23762.
     PubMed     Abstract available
     
     
     
110. KAPTEIN YE, Kaptein EM
     Comparison of subclavian vein to inferior vena cava collapsibility by ultrasound in acute heart failure: A pilot study.
     Clin Cardiol. 2021 Dec 21. doi: 10.1002/clc.23758.
     PubMed     Abstract available
     
     
     October 2021
111. EMMENS JE, Ter Maaten JM, Brouwers FP, Kieneker LM, et al
     Proenkephalin and the risk of new-onset heart failure: data from prevention of renal and vascular end-stage disease.
     Clin Cardiol. 2021 Oct 30. doi: 10.1002/clc.23729.
     PubMed     Abstract available
     
     
     
112. DIAO K, Wang D, Chen Z, Wu X, et al
     Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
     Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
     PubMed     Abstract available
     
     
     
113. LI N, Zhu Y, Zeng J
     Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure.
     Clin Cardiol. 2021 Oct 1. doi: 10.1002/clc.23738.
     PubMed     Abstract available
     
     
     September 2021
114. PACHECO C, Wei J, Shufelt C, C Hitzeman T, et al
     Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
     Clin Cardiol. 2021 Sep 16. doi: 10.1002/clc.23726.
     PubMed     Abstract available
     
     
     
115. BEL HAJ ALI K, Sekma A, Nouira S
     Response to "practical implication of nitroglycerin test for diagnosing heart failure in emergency department".
     Clin Cardiol. 2021 Sep 13. doi: 10.1002/clc.23721.
     PubMed    
     
     
     August 2021
116. ZHAO J, Zeng Y, Shen X
     Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis.
     Clin Cardiol. 2021 Aug 31. doi: 10.1002/clc.23717.
     PubMed     Abstract available
     
     
     
117. HIROI S, Izumida T, Imamura T
     Practical implication of nitroglycerin test for diagnosing heart failure in emergency department.
     Clin Cardiol. 2021 Aug 29. doi: 10.1002/clc.23722.
     PubMed    
     
     
     
118. MCCULLOUGH PA, Mehta HS, Barker CM, Van Houten J, et al
     Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
     Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23664.
     PubMed     Abstract available
     
     
     
119. SU Y, Hua W, Shen F, Zou J, et al
     Left ventricular-only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial.
     Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23616.
     PubMed     Abstract available
     
     
     July 2021
120. OSHIMA A, Imamura T, Narang N, Kinugawa K, et al
     Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
     Clin Cardiol. 2021 Jul 15. doi: 10.1002/clc.23683.
     PubMed     Abstract available
     
     
     
121. ZHANG D, Lai W, Liu X, Shen Y, et al
     The safety of morphine in patients with acute heart failure: A systematic review and meta-analysis.
     Clin Cardiol. 2021 Jul 8. doi: 10.1002/clc.23691.
     PubMed     Abstract available
     
     
     June 2021
122. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
     Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial.
     Clin Cardiol. 2021 Jun 28. doi: 10.1002/clc.23682.
     PubMed     Abstract available
     
     
     
123. BEAUVAIS F, Tartiere L, Pezel T, Motet C, et al
     First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology.
     Clin Cardiol. 2021 Jun 26. doi: 10.1002/clc.23666.
     PubMed     Abstract available
     
     
     
124. VAN WOERDEN G, van Veldhuisen DJ, Gorter TM, van Empel VPM, et al
     Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.
     Clin Cardiol. 2021 Jun 4. doi: 10.1002/clc.23644.
     PubMed     Abstract available
     
     
     
125. SEKMA A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al
     Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
     Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23615.
     PubMed     Abstract available
     
     
     May 2021
126. TAKABAYASHI K, Kitaguchi S, Yamamoto T, Takenaka K, et al
     Mode of death in elderly and super-elderly patients with acute heart failure: Insights from Japanese heart failure registry.
     Clin Cardiol. 2021 May 8. doi: 10.1002/clc.23619.
     PubMed     Abstract available
     
     
     
127. KOBAYASHI M, Voors AA, Ouwerkerk W, Duarte K, et al
     Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure.
     Clin Cardiol. 2021 May 7. doi: 10.1002/clc.23576.
     PubMed     Abstract available
     
     
     March 2021
128. WANG SJ, Cheng ZX, Fan XT, Lian YG, et al
     Development of an optimized risk score to predict short-term death among acute myocardial infarction patients in rural China.
     Clin Cardiol. 2021 Mar 25. doi: 10.1002/clc.23598.
     PubMed     Abstract available
     
     
     
129. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
     Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
     Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
     PubMed     Abstract available
     
     
     
130. LAM CSP, Wood R, Vaduganathan M, Bueno H, et al
     Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
     Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23585.
     PubMed     Abstract available
     
     
     February 2021
131. BRYAN RICHARD S, Huang B, Liu G, Yang Y, et al
     Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
     Clin Cardiol. 2021 Feb 27. doi: 10.1002/clc.23581.
     PubMed     Abstract available
     
     
     
132. YAZAKI M, Nabeta T, Ako J
     Response to letter to the editor entitled "Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure".
     Clin Cardiol. 2021 Feb 8. doi: 10.1002/clc.23563.
     PubMed    
     
     
     
133. CHAPMAN M, Imamura T
     Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure.
     Clin Cardiol. 2021 Feb 4. doi: 10.1002/clc.23562.
     PubMed    
     
     
     January 2021
134. CHEN J, Yu P, Ma J, Zheng C, et al
     Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator.
     Clin Cardiol. 2021 Jan 19. doi: 10.1002/clc.23547.
     PubMed    
     
     
     
135. PANDEY AC, Jer D, Kuo RS, Yoo DH, et al
     Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N-terminal pro B-type natriuretic peptide levels.
     Clin Cardiol. 2021;44:85-90.
     PubMed     Abstract available
     
     
     December 2020
136. LEE CJ, Ryu HY, Chun KH, Oh J, et al
     Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction.
     Clin Cardiol. 2020 Dec 25. doi: 10.1002/clc.23535.
     PubMed     Abstract available
     
     
     
137. SARIJALOO F, Park J, Zhong X, Wokhlu A, et al
     Predicting 90 day acute heart failure readmission and death using machine learning-supported decision analysis.
     Clin Cardiol. 2020 Dec 23. doi: 10.1002/clc.23532.
     PubMed     Abstract available
     
     
     November 2020
138. JOHANSEN ME, Argyropoulos C
     The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now.
     Clin Cardiol. 2020 Nov 9. doi: 10.1002/clc.23508.
     PubMed     Abstract available
     
     
     
139. MUK B, Vamos M, Bogyi P, Szabo B, et al
     The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
     Clin Cardiol. 2020 Nov 3. doi: 10.1002/clc.23500.
     PubMed     Abstract available
     
     
     October 2020
140. SHENG CC, Sahoo D, Dugar S, Prada RA, et al
     Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
     Clin Cardiol. 2020;43:1055-1063.
     PubMed     Abstract available
     
     
     September 2020
141. ARAI S, Kawamura M, Gokan T, Yoshikawa K, et al
     Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
     Clin Cardiol. 2020 Sep 29. doi: 10.1002/clc.23471.
     PubMed     Abstract available
     
     
     May 2020
142. ZAMANI SK, Samuel TJ, Wei J, Thomson LEJ, et al
     Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking.
     Clin Cardiol. 2020 May 27. doi: 10.1002/clc.23395.
     PubMed     Abstract available
     
     
     
143. JENTZER JC, Wiley B, Bennett C, Murphree DH, et al
     Early noncardiovascular organ failure and mortality in the cardiac intensive care unit.
     Clin Cardiol. 2020;43:516-523.
     PubMed     Abstract available
     
     
     March 2020
144. MARINI M, Branzoli S, Moggio P, Martin M, et al
     Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video-assisted thoracoscopic technique: Long-term outcome.
     Clin Cardiol. 2020;43:284-290.
     PubMed     Abstract available
     
     
     December 2019
145. HESS PL, Matlock DD, Al-Khatib SM
     Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
     Clin Cardiol. 2019 Dec 23. doi: 10.1002/clc.23315.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.